Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Every life sciences company knows that patient safety is non negotiable, but the way safety is managed—and the value ...

The Triangle’s life sciences sector is in the midst of one of the most significant growth waves in its history. But as the ...

Q4 2025 earnings call recap: 60% revenue growth, 2026 guidance of $60–$62M, PEDD/TriNav expansion, funding and risks—read now.

Gilead Sciences has agreed to buy the rest of development partner Arcellx in a deal that values the biotechnology company at about $7.8 billion at closing.

Add Yahoo as a preferred source to see more of our stories on Google. South Korea–based biotech firm 3billion plans to open a 13,000-square-foot AI-driven genetic testing lab in North Austin, a ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...

Caris Life Sciences Inc. CAI shares are up during Friday’s premarket session following better-than-expected fourth-quarter earnings and a significant interim readout from the company’s Achieve 1 study ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund ...

Following a difficult start in 2025, the ever-evolving life sciences segment recovered strongly in the latter half of the year.

The Penn Museum and the Academy of Natural Sciences of Drexel University have discontinued their long-running summer camp ...